These results suggest that Ras activation is important for the development of lymphoid and erythroid cells but not myeloid cells, and that Ras is a critical target of BCR/ABL in the pathogenesis of CML, but not B-ALL. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.